Avalon GloboCare Corp. (ALBT) - Market Cap to Earnings

Corporate emblem and logo of Avalon GloboCare Corporation (ALBT)

Avalon GloboCare collaborates with research hospitals to implement advanced cell therapy methods. This PE ratio chart for ALBT demonstrates a figure of -0.20. The business relies on strategic alliances in cancer diagnostics and the acquisition of US medical centers. The stable operation of diagnostic laboratories and equipment reliability guarantee uninterrupted patient admissions at the company's clinics.

Avalon GloboCare Corp - ALBT Price to Earnings Ratio (period 04/28/2023 - 07/22/2026)

Analytical breakdowns for Avalon GloboCare (ALBT)

- stock value and consensus price forecast:
Summary company analysis:ALBT, Avalon GloboCare Corp
Core merchandise of Avalon GloboCare Corporation

For Avalon GloboCare, which is developing synergy between cell therapy and laboratory diagnostics, this ratio determines the market value of each unit of net profit, reflecting investor expectations for the scaling of medical innovations. By analyzing the P/E chart, the user assesses the degree of overpayment for the asset, where the price action distinguishes fundamental business strengthening from short-term speculative fluctuations in quotes.

Analysis of competing companies

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Price to Earnings Ratio Solventum SOLV|Market Price to Net Income Ratio EHC (Encompass Health)|UHS: Price to Earnings Ratio|DVA (DaVita) - Price to Earnings Multiple|RadNet Corp (RDNT) - Price to Earnings Ratio|Market Cap to Earnings Option Care Corp (OPCH)|Price to Earnings Ratio SGRY|PINC: Company Value to Net Income|P/E Multiple EYE|PGNY - Market Cap to Earnings|P/E Multiple ARDT (ardenthealth.com)|SEM - Price to Earnings Ratio|Astrana Corp - P/E Multiple|Company Value to Net Income MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Price to Earnings Ratio|Market Cap to Earnings Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E Multiple|NUTX: Company Value to Net Income|P/E Multiple AUNA|Price to Earnings Ratio SBC Medical Group Holdings Inc SBC|Price to Earnings Ratio Jeuveau EOLS|Company Value to Net Income CYH|SKIN: Price to Earnings Ratio|Company Value to Net Income MDWD (MediWound)|BTMD (biote.com) - Price to Earnings Ratio|Price to Earnings Ratio thejoint.com|DCGO (DocGo, Inc.) - P/E Multiple|Price to Earnings Ratio PIII|Price to Earnings Ratio GANX (Gain Therapeutics Inc.)|P/E Multiple EUDA Health (EUDA)|Basel Medical Group - Price to Earnings Ratio|Market Price to Net Income Ratio CLGN (CollPlant Ltd)|cuprina.com.sg - P/E Multiple|Company Value to Net Income CCM (Concord Medical Services Holdings)|AMS: P/E Multiple|Market Cap to Earnings MEDIROM Corp (MRM)|Price to Earnings Ratio DIH Holding|XAGE: Company Value to Net Income|P/E Multiple NIVF|P/E Multiple ATI Physical Therapy Inc. (ATIP)|P/E Multiple CMAX (caremax.com)|Market Price to Net Income Ratio KDLY (Kindly Health)|MODV - Price to Earnings Ratio|Market Cap to Earnings novointegrated.com|SunLink Health Systems (SSY) - Price to Earnings Ratio|Price to Earnings Ratio IMAC Holdings Inc